TY - JOUR
T1 - Development of an extension of the OMERACT Summary of Measurement Properties table to capture equity considerations
T2 - SOMP-Equity
AU - Petkovic, Jennifer
AU - Umaefulam, Valerie
AU - Wattiaux, Aimée
AU - Bartels, Christie
AU - Barnabe, Cheryl
AU - Greer-Smith, Regina
AU - Hofstetter, Catherine
AU - Maxwell, Lara
AU - Shea, Beverley
AU - Barton, Jennifer
AU - Lee, Alex Young Soo
AU - Humphreys, Jennifer
AU - Beaton, Dorcas
AU - Tugwell, Peter
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/12
Y1 - 2021/12
N2 - Objective: To develop an equity extension of the OMERACT Summary of Measurement Properties (SOMP) Table, SOMP Equity to describe whether a patient reported outcome measure (PROM) works well among patients of diverse languages and cultures, education levels, and other population characteristics. Methods: We used the PROGRESS-Plus framework to categorize equity characteristics assessed in trials of PROM. PROGRESS refers to Place of residence, Race/ethnicity/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, and Social Capital, while the ‘plus’ captures additional characteristics, such as age. We pilot tested our SOMP Equity Extension using the Health Assessment Questionnaire (HAQ) as a prototypical PROM. Results: The SOMP Equity Extension retains the same columns as the original OMERACT SOMP (domain match, feasibility, construct validity, test-retest reliability, longitudinal construct validity, clinical trial discrimination, thresholds of meaning) but uses the PROGRESS-Plus characteristics as rows. We found several examples of studies of the HAQ which had assessed one or more PROGRESS-Plus characteristics. Conclusions: The most commonly reported equity considerations were related to language. OMERACT Equity virtual meeting participants were polled and they indicated that the SOMP Equity Extension is useful for highlighting and tracking equity considerations for OMERACT Core Outcome Measurement Instruments.
AB - Objective: To develop an equity extension of the OMERACT Summary of Measurement Properties (SOMP) Table, SOMP Equity to describe whether a patient reported outcome measure (PROM) works well among patients of diverse languages and cultures, education levels, and other population characteristics. Methods: We used the PROGRESS-Plus framework to categorize equity characteristics assessed in trials of PROM. PROGRESS refers to Place of residence, Race/ethnicity/culture/language, Occupation, Gender/sex, Religion, Education, Socioeconomic status, and Social Capital, while the ‘plus’ captures additional characteristics, such as age. We pilot tested our SOMP Equity Extension using the Health Assessment Questionnaire (HAQ) as a prototypical PROM. Results: The SOMP Equity Extension retains the same columns as the original OMERACT SOMP (domain match, feasibility, construct validity, test-retest reliability, longitudinal construct validity, clinical trial discrimination, thresholds of meaning) but uses the PROGRESS-Plus characteristics as rows. We found several examples of studies of the HAQ which had assessed one or more PROGRESS-Plus characteristics. Conclusions: The most commonly reported equity considerations were related to language. OMERACT Equity virtual meeting participants were polled and they indicated that the SOMP Equity Extension is useful for highlighting and tracking equity considerations for OMERACT Core Outcome Measurement Instruments.
KW - OMERACT
KW - Patient-reported outcome measures
KW - equity
KW - inequalities
KW - social determinants of health
UR - http://www.scopus.com/inward/record.url?scp=85116701870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116701870&partnerID=8YFLogxK
U2 - 10.1016/j.semarthrit.2021.09.005
DO - 10.1016/j.semarthrit.2021.09.005
M3 - Article
C2 - 34625296
AN - SCOPUS:85116701870
SN - 0049-0172
VL - 51
SP - 1300
EP - 1310
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
IS - 6
ER -